Explore tweets tagged as #visualabstract
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy ca. 2025 from @NEJM
#Nephpearls #KidneyWk
#VisualAbstract by @NephroSeeker @NephJC ๐๐ผ https://t.co/XlG8LwsUmy
3
6
33
Evaluating #Sibeprenlimab in #IgA Nephropathy - Rationale and Baseline Data from the #VISIONARY Trial #VisualAbstract by @nephromythri
https://t.co/aQk3TGahLt
0
8
24
Sibeprenlimab in IgA Nephropathy: Interim Analysis of a Phase 3 Trial ca. 2025 from @NEJM
#Nephpearls #KidneyWk
#VisualAbstract by @NephroSeeker @NephJC ๐๐ผ https://t.co/6GICMthDNA
3
7
33
Effect of Baseline #Dialysis and #PlasmaExchange on Renal Prognosis in Patients with #ANCA Associated Vasculitis #VisualAbstract by @NephroSeeker
https://t.co/6O7srTIqmJ
0
20
46
1/ After many years of editing, I'm thrilled to release the 5th edition of the Visual Abstract Primer! Notably, its a lot short (11 pages, down from 56!) Full download here: https://t.co/GaDTPzhdw7 Summary below... #VisualAbstract
10
79
224
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload ca. 2023 from @NEJM
#NephJC #Nephpearls #Cardiorenal #AKIinICU
#VisualAbstract by @Api_chew ๐๐ผ https://t.co/uSW0ym5KDw
0
16
44
#MassSpectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis #MCD #FSGS
#VisualAbstract by @sophia_kidney
https://t.co/QOxgbBYBw2
0
20
44
๐ Do we really need to add PPI for all the patients who are on corticosteroids? Or โ๏ธWe are just adding to the cost and pill burden to the pts ๐ฅ https://t.co/yJC5d9Yfkr
#VisualAbstract by @SuchitaSata
2
23
61
#Socioeconomic #Deprivation and Kidney #Transplant Outcomes #VisualAbstract by @Cteodosiu
https://t.co/RZw49E52qr
0
2
4
#LiverCyst #Infection Outcomes in Patients With Autosomal Dominant Polycystic Kidney Disease #ADPKD
#VisualAbstract by @KajareeG
https://t.co/a7V73x3pua
0
6
13
The #VisualAbstract has come a long way in 7 years: โ
5 RCTs demonstrating reproducible โฌ๏ธdissemination โ
Adoption by >100 journals & orgs โ
open source primer approaching 5th Ed. Yet, there is so much more it can do to improve patient care: https://t.co/OvPI2CveGM
0
18
54
Outcomes of Initiating Peritoneal Dialysis versus Hemodialysis in Severe, Symptomatic Kidney Failure ca. 2025 from @asnpublications
#Nephpearls #BestofKidney360 #KidneyWk
#VisualAbstract by @Vernisartan ๐ https://t.co/AgiZAjhuzL
0
17
58
Early #GoalDirected Hemostatic Therapy for Severe Acute Bleeding Management in the #ICU
https://t.co/4gm8drClZJ
#Transfusion #TransfusionMedicine #visualabstract #POCT
0
7
24
Longitudinal Trajectories of Chronic #Kidney Disease-Associated #Pruritus
#VisualAbstract by @KajareeG
https://t.co/Y4yxGnaOa1
1
5
11
Effects of Once-Weekly ๐ Semaglutide #Nephpearls #Cardiorenal
#VisualAbstract by @AnjanaGopal9 @kidney_boy @brian_rifkin FLOW ๐ https://t.co/DwXn853t6k SUSTAIN 6 ๐ https://t.co/HzvdjLJVfg SUSTAIN 6 Posthoc ๐ https://t.co/4F6VABgwgd Nice write up here by @kidney_boy ๐
2
42
113
Kidney Replacement Therapy #KRT Within 12 Months of #Childbirth in #Australia
#VisualAbstract by Morgan McCord https://t.co/YqKey7h1z5
1
2
4
The Effects of #Clazakizumab on #PeripheralBlood and Kidney #Transcriptomes in Patients With Late Antibody-Mediated Rejection #ABMR
#VisualAbstract by @RenzPasilan
https://t.co/yi7nxGgXsX
1
8
25
#Barriers to and #Facilitators of #Phosphate Control in #Children With CKD #VisualAbstract by @md_abdulqader83
https://t.co/S1XWEbjqf0
0
7
9
Ameliorative Effect of an AntiโMicroRNA-21 Oligonucleotide on Animal and Human Models of Cystic Kidney Disease ca. 2025 from @asnpublications
#Nephpearls #BestofKidney360 #KidneyWk
#VisualAbstract by @HecmagsMD ๐ https://t.co/iqMpi2dcam
1
3
3